Related references
Note: Only part of the references are listed.Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Luca Lazzari et al.
CLINICAL CANCER RESEARCH (2019)
Genomic heterogeneity in primary colorectal carcinomas and their metastases: born bad or brought up a villain?
Maja Huehns et al.
HUMAN PATHOLOGY (2018)
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies
Mariangela Russo et al.
NATURE COMMUNICATIONS (2018)
Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line
Michael Gock et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Establishment, functional and genetic characterization of three novel patient-derived rectal cancer cell lines
Michael Gock et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts
Magdalena Cybulska et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Modeling of Patient-Derived Xenografts in Colorectal Cancer
Anastasia Katsiampoura et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome
Claudia Maletzki et al.
MOLECULAR CARCINOGENESIS (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment
Friedrich Prall et al.
PLOS ONE (2017)
The ghosts of HeLa: How cell line misidentification contaminates the scientific literature
Serge P. J. M. Horbach et al.
PLOS ONE (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Improved survival of colorectal cancer in Denmark during 2001-2012-The efforts of several national initiatives
Lene H. Iversen et al.
ACTA ONCOLOGICA (2016)
Establishment and characterization of HROC69-a Crohn's related colonic carcinoma cell line and its matched patient-derived xenograft
Florian Kuehn et al.
SCIENTIFIC REPORTS (2016)
Diagnostics and Epidemiology of Colorectal Cancer
Frank T. Kolligs
VISCERAL MEDICINE (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Correlation between tumor engraftment in patient-derived xenograft models and clinical outcomes in colorectal cancer patients
Bo Young Oh et al.
ONCOTARGET (2015)
Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor
Hyang Sook Seol et al.
CANCER LETTERS (2014)
A Personalized Preclinical Model to Evaluate the Metastatic Potential of Patient-Derived Colon Cancer Initiating Cells
Isabel Puig et al.
CLINICAL CANCER RESEARCH (2013)
The North German Tumor Bank of Colorectal Cancer: status report after the first 2 years of support by the German Cancer Aid Foundation
Martina Oberlaender et al.
LANGENBECKS ARCHIVES OF SURGERY (2013)
Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison
Christina Susanne Mullins et al.
PLOS ONE (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas
Claudia Maletzki et al.
PLOS ONE (2012)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Colorectal Cancer Incidence Trends in the United States and United Kingdom: Evidence of Right- to Left-Sided Biological Gradients with Implications for Screening
Rafael Meza et al.
CANCER RESEARCH (2010)
Biomarker-Driven Early Clinical Trials in Oncology A Paradigm Shift in Drug Development
Daniel S. W. Tan et al.
CANCER JOURNAL (2009)
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: Comparison of success rate and cell line features
Virginie Dangles-Marie et al.
CANCER RESEARCH (2007)
Share Paper
